cialisisa[.]com

This domain, cialisisa.com, is flagged as part of a generic phishing infrastructure impersonating pharmaceutical brands to distribute counterfeit or unregulated medications. Analysis indicates no direct association with a known drainer kit or cryptocurrency fraud, but the domain follows patterns consistent with fake online pharmacies targeting consumers seeking prescription drugs without verification. The lack of brand-specific indicators suggests a broader, opportunistic campaign rather than a targeted impersonation effort. Infrastructure analysis reveals the domain was registered on April 28, 2026, through Fewmoretaps OU d/b/a Trustname.com, a registrar frequently observed in low-reputation hosting schemes. It resolves to IP address 3.71.180.249, hosted on AWS EC2 in the eu-central-1 region (Germany). VirusTotal reports 0/95 detections, indicating no antivirus engines currently flag the domain as malicious. However, it appears on one security blocklist, suggesting preliminary detection by at least one threat intelligence feed. The SSL certificate is issued by Let's Encrypt (R13), a common choice for both legitimate and malicious domains due to its low-cost, automated issuance process. As of the latest assessment, cialisisa.com remains active and unresolved by major security providers, including Google Safe Browsing. The domain has been preemptively blocked by at least one proprietary threat feed, though the absence of broader detection suggests either early-stage deployment or evasion techniques. Organizations are advised to monitor for DNS resolutions to 3.71.180.249 and evaluate web traffic patterns for pharmaceutical-related phishing attempts. Given the domain's recent registration and minimal detection footprint, continued observation is recommended to assess potential escalation in malicious activity.